These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
3. [Options and strategy for the treatment of chronic endogenous uveitis]. Garweg JG Klin Monbl Augenheilkd; 2007 Apr; 224(4):367-72. PubMed ID: 17458817 [TBL] [Abstract][Full Text] [Related]
5. [New methods of therapy for ocular inflammatory autoimmune diseases]. Kubicka-Trzaska A; Undas A Klin Oczna; 2003; 105(6):428-32. PubMed ID: 15049272 [TBL] [Abstract][Full Text] [Related]
6. [The lack of awareness of the Israeli population regarding gastrointestinal complications from non-steroidal anti-inflammatory drugs]. Zandman-Goddard G; Langevitz P Harefuah; 2001 Jun; 140(6):476-8, 567, 566. PubMed ID: 11420844 [TBL] [Abstract][Full Text] [Related]
7. The use and safety profile of non-steroidal antiinflammatory drugs among Turkish patients with osteoarthritis. Yilmaz H; Gürel S; Ozdemir O Turk J Gastroenterol; 2005 Sep; 16(3):138-42. PubMed ID: 16245223 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive agents and nonsteroidal anti-inflammatory drugs for ocular immune and inflammatory disorders. Hemady RK; Chan AS; Nguyen AT Ophthalmol Clin North Am; 2005 Dec; 18(4):511-28, vi. PubMed ID: 16314216 [TBL] [Abstract][Full Text] [Related]
9. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome. Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875 [TBL] [Abstract][Full Text] [Related]
10. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
12. [Alternatives to steroid therapy in chronic uveitis]. Klein S; Fricke HJ; Fricke B; Friedrich R; Illessy A; Schröder KD Fortschr Ophthalmol; 1990; 87(4):355-8. PubMed ID: 2210561 [TBL] [Abstract][Full Text] [Related]
13. Management of chronic musculoskeletal pain in the elderly: opinions on oral medication use. Kean WF; Rainsford KD; Kean IR Inflammopharmacology; 2008 Apr; 16(2):53-75. PubMed ID: 18389178 [TBL] [Abstract][Full Text] [Related]
14. Selective COX-2 inhibitors: a review of their therapeutic potential and safety in dentistry. May N; Epstein J; Osborne B Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Oct; 92(4):399-405. PubMed ID: 11598574 [TBL] [Abstract][Full Text] [Related]
15. Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis. Mizuguchi J; Takeuchi M; Usui M Arch Immunol Ther Exp (Warsz); 2002; 50(4):243-54. PubMed ID: 12371620 [TBL] [Abstract][Full Text] [Related]
16. Uveitis. Muñoz-Fernández S; Martín-Mola E Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):487-505. PubMed ID: 16777578 [TBL] [Abstract][Full Text] [Related]
17. Treatment of autoimmune disease: time for a paradigm shift? Mor F Arch Immunol Ther Exp (Warsz); 2007; 55(1):13-8. PubMed ID: 17221336 [TBL] [Abstract][Full Text] [Related]